KYTOPEN
Kytopen is a developer of a cell therapy platform designed for non-viral delivery of molecules into hard-to-transfect immune cells. The company's technology combines microfluidics and automation to make non-viral delivery of molecules easier, faster and cheaper through an automated cell engineering platform, enabling researchers to find new discoveries in biology that will lead to cost effective cell and gene therapies.
KYTOPEN
Social Links:
Industry:
Biotechnology Genetics Health Care Life Science
Founded:
2017-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.kytopen.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
37.12 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Euro Microsoft Exchange Online Office 365 Mail Google Maps Microsoft Azure DNS
Similar Organizations
Rightangled
Medtech specialised in Genetics, Blood and infection testing. Service is delivers through a platform that connects users with specialists.
NED Biosystems
NED Biosystems Developing proprietary combination cancer therapy. Other IP includes diagnostics.
Notch Therapeutics
The notch develops immune cell therapy developing a next-generation pipeline that is compatible and focuses on initial cancer cells.
VistaPath Biosystems
VistaPath Biosystems develops a tissue grossing platform that automates the process of inspecting, inking, and measuring tissues.
Vyv
Vyv offers an antimicrobial light for germ control through safe, continuous LED products.
VIC Technology Venture Development
VIC Technology Venture Development develops healthcare and technology companies focusing on improving quality of life.
Veritas Intercontinental
Genetics.The mission of Veritas Int. is to fulfill the promise of the human genome, empowering people to maximize quality and length of life
Voyager Therapeutics
Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.
Variantyx
Variantyx is a molecular diagnostics company specializing in advanced genetic testing and diagnostics.
Verve Therapeutics
Verve Therapeutics is a genetic medicine firm that is developing treatments for cardiovascular disease.
Mogrify
Mogrify® will transform the development of ex vivo cell therapies and pioneer a new class of in vivo reprogramming therapies.
Mammoth Biosciences
Mammoth Biosciences develops novel CRISPR applications for disease detection, research, agriculture, biodefense, and more.
Mirimus
Mirimus is a producer of custom genetically-engineered mouse models with reverse gene silencing capabilities.
Microba Life Sciences
Microba Life Sciences is a precision microbiome science company powering medical innovation to transform human health.
Magnetic Insight
MPI enables best in class cellular imaging to measure the efficacy of cancer immunotherapies.
MiRXES
MiRXES discover, develop, and deliver accurate preventive healthcare solutions.
LifeQ
LifeQ has a mission to create a world where people from all walks of life enjoy optimal health and wellbeing.
Ligandal
Ligandal is creating delivery systems and AI-driven targeting approaches for cell-specific and precision genetic medicine.
L7 Informatics
L7 Informatics provides a workflow management software platform for companies using data-intensive scientific techniques.
ALDOCK
ALDOCK develops a groundbreaking risk test that will help in the early detection of cancer.
Athelas
Athelas develops technology to monitor chronically ill patients in their homes.
Refeyn
Refeyn is specialising in label-free single molecule imaging and mass measurement.
Genomelink
Genomelink is a platform where people discover more with their DNA data and help businesses build, market, and do research with it.
AavantiBio
AavantiBio is a biopharmaceutical company that provides gene transfer and gene editing therapies to treat genetic diseases.
Allelica
Allelica is a genomics software company driving the transition of Polygenic Risk Score from Genomic research to clinical application.
Avitide
Avitide develops affinity purification solutions for biopharmaceutical companies.
A-Alpha Bio
A-Alpha Bio is a provider of cell-based tools for quantitative and high-throughput measurements of protein interactions.
Biofidelity
Biofidelity developed a revolutionary molecular diagnostics.
FoxBio
FoxBio is a Company that will develop Antoxerene’s collection of small molecules that target senescent cells.
FerGene
FerGene is an new Gene therapy, spin off Ferring Pharmaceuticals.
TMRW Life Sciences
TMRW Life Sciences provides an integrated platform for automated, software-guided cryospecimen management.
The ODIN
The ODIN provides kits and tools that helps consumers make organisms at home.
TeraImmune
TeraImmune is a developer of cell therapeutics created for autoimmune diseases and immune-related disorders.
Kanyos Bio
Kanyos Bio was founded with the goal of developing antigen-specific immune tolerance technology for two specific autoimmune indications.
Synlife
Synlife is innovating new therapeutic and diagnostic platforms through bottom-up engineering of synthetic cells.
Senda Biosciences
Senda Biosciences is a therapeutics platform company leveraging unprecedented insights into the molecular connections between humans.
Savran Technologies
Savran Technologies offers non-invasive diagnostics based on capture and analysis of rare cells.
Scipher Medicine
Scipher Medicine develops a healthcare platform designed to determine which drug will work best for each patient.
SOMOS
SOMOS is offering genetic solutions that put at your disposal tests of global ancestry and Latin American ancestry.
Scioto Biosciences
Scioto is a developer of Activated Bacterial Therapeutics platform.
Droplette
Droplette is a needle-free and hand-held device that delivers large molecules deep through skin.
HotSpot Therapeutics
HotSpot Therapeutics is a developer of a therapy platform designed to discover medicines and provide proper treatment.
Hyris
Hyris is offers an integrated platform for decentralized nucleic acid testing Products.
hC Bioscience
hC Bioscience is an innovator and pioneer of protein editing using context agnostic engineered tRNA.
Eva
Eva develops an accessible and non-invasive wearable device designed to detect breast cancer risks.
Indee Labs
Indee Labs is unlocking gene-modified cell therapy for the masses with scalable hardware for gene delivery.
Inceptor Bio
Inceptor Bio develops cell therapy solutions to cure difficult-to-treat cancers.
Geneoscopy
Geneoscopy develops a screening methodology to noninvasively diagnose colorectal cancer using biomarkers in stool samples.
Fabric Genomics (formerly Omicia)
Global healthcare platform for genomics-driven precision medicine. Fabric' proven AI algorithms power genomic insights.
XinThera
XinThera is a drug discovery company focused on building small molecule oncology and immunology pipeline.
X-Therma
X-Therma is a biotechnology firm that develops a convergent biopreservation platform to advance regenerative medicine.
Zymtronix
Zymtronix develops a patented platform technology that allows innovative and efficient enzyme processes.
Cystetic Medicines
Cystetic Medicines develops a treatment that potentially could help people with cystic fibrosis (CF), regardless of genetic mutation.
CASPR Biotech
CASPR Biotech develops a CRISPR-based platform for molecular detection.
Canopy Biosciences
Canopy Biosciences aims to accelerate the commercialization of life science reagent tools and services through in-licensing.
CirculoGene Theranostics
CirculoGene specializes in the fields of cfDNA, liquid biopsy, tumor monitoring, laboratory testing, and molecular diagnostics.
Cytena
Cytena develops single-cell printing technology for cell research and professional diagnostics.
CS Genetics
CS Genetics develops new technology for genomics, based on scientific insights and conceptual innovations in NGS techniques.
ColonaryConcepts
ColonaryConcepts develops a medical platform intended to promote gastrointestinal health.
Centrillion Technologies
Centrillion Biosciences develops genomics and DNA analyses technology for personalized medicine, life sciences research, and bioinformatics.
Cell Vault
Cell Vault offers a t-cell bank that gives healthy individuals an opportunity to jumpstart their fight against cancer.
Creyon Bio
Reinventing drug development from the ground up to make safe, effective oligonucleotide-based medicines possible on demand.
Corisma
Corisma develops a catheter implanted circulatory assist device designed to treat patients suffering from advanced heart failure.
Plasticell
Plasticell offers a cell-based screening technology for the discovery of small molecule drugs that regenerate cells of the body.
Current Advisors List
Current Employees Featured
Founder
Investors List
TBD Angels
TBD Angels investment in Series A - Kytopen
Northpond Ventures
Northpond Ventures investment in Series A - Kytopen
MassVentures
MassVentures investment in Series A - Kytopen
The Engine
The Engine investment in Series A - Kytopen
Horizon Ventures
Horizon Ventures investment in Series A - Kytopen
Alexandria Venture Investments
Alexandria Venture Investments investment in Series A - Kytopen
John Ballantyne
John Ballantyne investment in Series A - Kytopen
Michael Chambers
Michael Chambers investment in Series A - Kytopen
National Institute of Allergy and Infectious Diseases
National Institute of Allergy and Infectious Diseases investment in Grant - Kytopen
TBD Angels
TBD Angels investment in Angel Round - Kytopen
Official Site Inspections
http://www.kytopen.com Semrush global rank: 3.74 M Semrush visits lastest month: 3.64 K
- Host name: 199.60.103.45
- IP address: 199.60.103.45
- Location: Canada
- Latitude: 43.6319
- Longitude: -79.3716
- Timezone: America/Toronto
More informations about "Kytopen"
Leadership - Kytopen
Kytopen is proud to be founded as a spin out of Dr. Buie's laboratory, where Dr. Garcia worked as a post-doctoral researcher, at the Massachusetts Institute of Technology. Cullen Buie, PhD. …See details»
Kytopen - Crunchbase Company Profile & Funding
Kytopen is a developer of a cell therapy platform designed for non-viral delivery of molecules into hard-to-transfect immune cells. The company's technology combines microfluidics and automation to make non-viral delivery of …See details»
Kytopen Raises $30M in Series A Funding, Led by …
Sep 28, 2021 “Kytopen is unlocking potential in genetic engineering at speeds 10,000 faster than current state-of-the-art methods while still maintaining cellular composition. Northpond is excited to collaborate with Kytopen to advance non …See details»
Kytopen - LinkedIn
Kytopen is focused on the development and commercialization of groundbreaking genome engineering platforms for expediting the discovery, development, and manufacture of gene-modified cell therapies.See details»
Kytopen Company Profile 2024: Valuation, Funding
Kytopen General Information Description. Developer of a cell engineering platform designed to offer healthy and functional cells. The company's tool uses a fast, scalable, and gentle process that yields quality engineered cells in …See details»
Kytopen | STEX - Startup
Apr 13, 2020 Kytopen is currently focused on the growing field of immuno-therapy—an area that ties closely to Garcia’s personal research interests. But the technology has potential in many fields, including vaccine development. Early …See details»
Kytopen - Funding, Financials, Valuation & Investors - Crunchbase
Kytopen developer of a cell therapy platform for non-viral delivery of molecules into hard-to-transfect immune cells. Search Crunchbase. Start Free Trial . ... How much funding has this …See details»
Kytopen Company Profile - Office Locations, Competitors ... - Craft
Kytopen is a company that develops platforms to accelerate the discovery and manufacturing of gene-modified cell therapies. It offers Flowfect, a proprietary non-viral cell engineering …See details»
On a Journey to Drastically Speed Up Cell Therapy ... - Kytopen
Oct 4, 2021 The way Kytopen manufactures at small scale is also the same way it’s done at a larger scale. Buie compared it to cooking pasta: just because the group is making more pasta, …See details»
Kytopen Corporation | STEX - Startup
Apr 13, 2020 Kytopen enables transformative therapies with our patent-pending continuous Flowfectâ„¢ cell engineering platforms. The non-viral Flowfectâ„¢ technology is a fast, scalable, …See details»
Kytopen - Contacts, Employees, Board Members, Advisors & Alumni
Organization. Kytopen . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies ... Kytopen has 4 current employee profiles, including Co …See details»
Kytopen FlowFect™ Platform to Be Used in GMP-Manufacture of …
Jul 16, 2024 Kytopen, headquartered in Cambridge, Massachusetts with an R&D site in Denver, Colorado, is a leading biotechnology company specializing in the development and …See details»
Kytopen Raises $30M in Series A Funding, Led by Northpond …
Sep 28, 2021 Kytopen, a spin-out of Prof. Cullen Buie’s lab at MIT, is a transformative biotechnology company that offers a customizable yet scalable multi-solution platform, which …See details»
Kytopen Names Michael Chiu, Ph.D., as Chief Executive Officer
Aug 7, 2023 Dr. Chiu joins Kytopen at the time of its accelerated roll-out of the Flowfect ® technology to high-profile academic medical centers in the U.S. Prior to this, he was the Chief …See details»
Kytopen Reveals Automated High-Throughput Gene Editing …
May 24, 2023 Kytopen is an MIT startup developing platforms to accelerate the discovery, development, and manufacturing of gene-modified cell therapies. The scalable Flowfect® …See details»
BioCentriq & Kytopen Announce Cell Therapy Manufacturing …
NEWARK, NJ, March 23, 2021 – BioCentriqâ„¢, the New Jersey Innovation Institute’s cell and gene therapy development and manufacturing center, announces its partnership with Kytopen, …See details»
Greg Crescenzi Joins Kytopen as Chief Commercial Officer to Drive ...
Mar 30, 2021 Kytopen, an MIT spin-out company, has recently made its Flowfect ® Tx system available to select bio-pharma partners and collaborators to accelerate their engineered cell …See details»
BioCentriq® and Kytopen® Expand Partnership to Expedite …
Jun 6, 2023 About Kytopen. Kytopen is an MIT startup developing platforms to accelerate the discovery, development, and manufacturing of gene-modified cell therapies. The scalable …See details»
Kytopen Announces Launch of Technology Access Program …
Mar 26, 2024 Kytopen Corp., a leader in the development of manufacturing platforms and workflows for advanced therapeutic medicines, announces the launch of the Flowfect® …See details»
News - Kytopen
Aug 13, 2024 Kytopen awarded competitive phase II SBIR fast-track funding for “Non-Activated Natural Killer... Kytopen. August 13, 2024 Technology Partners. Kytopen FlowFectâ„¢ Platform …See details»